Publications by authors named "Patrick McCollam"

Claim this Profile
C
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study.
Kari Kelton, Tim Klein, Dan Murphy, Mark Belger, Erik Hille, Patrick L McCollam

Adv Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.
Mark B Effron, Kavita V Nair, Cliff Molife, Stuart Y Keller, Robert L Page, Patrick L McCollam

Am J Cardiovasc Drugs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.
Patricia O Guimarães, Arun Krishnamoorthy, Lisa A Kaltenbach, Kevin J Anstrom, Mark B Effron, Patrick L McCollam

JAMA Cardiol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs.
Keith L Davis, Juliana Meyers, Zhenxiang Zhao, Patrick L McCollam, Masahiro Murakami

J Atheroscler Thromb· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.
Cliff Molife, Feride Frech-Tamas, Mitch DeKoven, Mark B Effron, Swapna Karkare, Patrick McCollam

J Med Econ· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Padma Kaul, E Magnus Ohman, J David Knight, Kevin J Anstrom, Matthew T Roe, Patrick McCollam

Am Heart J· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies.
Arun Krishnamoorthy, Eric D Peterson, J David Knight, Kevin J Anstrom, Mark B Effron, Patrick L McCollam

J Am Heart Assoc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel.
Jason C Simeone, Cliff Molife, Elizabeth Marrett, Feride Frech-Tamas, Mark B Effron, Patrick L McCollam

Am J Cardiovasc Drugs· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in low-density lipoprotein cholesterol levels after discharge for acute myocardial infarction in a real-world patient population.
Suzanne V Arnold, Mikhail Kosiborod, Fengming Tang, Zhenxiang Zhao, Patrick L McCollam

Am J Epidemiol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction.
Suzanne V Arnold, Mikhail Kosiborod, Fengming Tang, Zhenxiang Zhao, Thomas M Maddox, Patrick L McCollam

Circulation· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention.
Beth L Nordstrom, Jason C Simeone, Zhenxiang Zhao, Cliff Molife, Patrick L McCollam

Am J Cardiovasc Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and dosing frequency of common medications for cardiovascular patients.
Jay P Bae, Paul P Dobesh, Donald G Klepser, Johnna D Anderson, Anthony J Zagar, Patrick L McCollam

Am J Manag Care· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities for pharmacotherapy at the intersection of metabolic syndrome and hemostasis.
Laura F Michael, Veena Rao, Patrick McCollam, Mark C Kowala, John Wetterau

Curr Pharm Biotechnol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential unrecognised costs of clopidogrel pretreatment in acute coronary syndrome.
Jay P Bae, Paul P Dobesh, Patrick L McCollam, Ali Khoynezhad

J Med Econ· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Baojin Zhu, Zhenxiang Zhao, Patrick McCollam, Johnna Anderson, Jay P Bae

Curr Med Res Opin· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of care for new versus recurrent acute coronary syndrome patients.
Sharashchandra Shetty, Rachel Halpern, Patrick L McCollam

J Med Econ· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapy.
Josephine A Mauskopf, Kristina S Boye, Claude Schmitt, Patrick McCollam, Julie Birt

J Med Econ· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel loading doses and outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Cheng Wang, Dean J Kereiakes, Jay P Bae, Patrick McCollam, Jianming He

J Invasive Cardiol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute coronary syndromes in Europe: 1-year costs and outcomes.
Matthew J Taylor, Paul A Scuffham, Patrick L McCollam, David E Newby

Curr Med Res Opin· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of high-cost managed care patients with acute coronary syndrome.
Lida R Etemad, Patrick L McCollam

Curr Med Res Opin· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
Patrick McCollam, Lida Etemad

J Invasive Cardiol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total first-year costs of acute coronary syndrome in a managed care setting.
Lida R Etemad, Patrick L McCollam

J Manag Care Pharm· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid assessment of well-being: The Short Depression-Happiness Scale (SDHS).
Stephen Joseph, P Alex Linley, Jake Harwood, Christopher Alan Lewis, Patrick McCollam

Psychol Psychother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Patrick L McCollam, David A Foster, Jeffrey S Riesmeyer

Am J Health Syst Pharm· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis